1 Market Overview
1.1 Product Overview and Scope of Oncology Radiopharmaceutical
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oncology Radiopharmaceutical Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Drugs
1.3.3 Intravenous Drugs
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Oncology Radiopharmaceutical Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Pharmaceutical Company
1.4.4 Research Center
1.4.5 Other
1.5 Global Oncology Radiopharmaceutical Market Size & Forecast
1.5.1 Global Oncology Radiopharmaceutical Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oncology Radiopharmaceutical Sales Quantity (2018-2029)
1.5.3 Global Oncology Radiopharmaceutical Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Oncology Radiopharmaceutical Product and Services
2.1.4 Novartis Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Chimeric Therapeutics Limited
2.2.1 Chimeric Therapeutics Limited Details
2.2.2 Chimeric Therapeutics Limited Major Business
2.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product and Services
2.2.4 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Chimeric Therapeutics Limited Recent Developments/Updates
2.3 Fusion Pharma
2.3.1 Fusion Pharma Details
2.3.2 Fusion Pharma Major Business
2.3.3 Fusion Pharma Oncology Radiopharmaceutical Product and Services
2.3.4 Fusion Pharma Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fusion Pharma Recent Developments/Updates
2.4 Lantheus Medical lmaging, Inc.
2.4.1 Lantheus Medical lmaging, Inc. Details
2.4.2 Lantheus Medical lmaging, Inc. Major Business
2.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product and Services
2.4.4 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lantheus Medical lmaging, Inc. Recent Developments/Updates
2.5 NanoMab
2.5.1 NanoMab Details
2.5.2 NanoMab Major Business
2.5.3 NanoMab Oncology Radiopharmaceutical Product and Services
2.5.4 NanoMab Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NanoMab Recent Developments/Updates
2.6 NuView Life Sciences.
2.6.1 NuView Life Sciences. Details
2.6.2 NuView Life Sciences. Major Business
2.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Product and Services
2.6.4 NuView Life Sciences. Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 NuView Life Sciences. Recent Developments/Updates
2.7 PentixaPharm GmbHPrecirix
2.7.1 PentixaPharm GmbHPrecirix Details
2.7.2 PentixaPharm GmbHPrecirix Major Business
2.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product and Services
2.7.4 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 PentixaPharm GmbHPrecirix Recent Developments/Updates
2.8 RadioMedix
2.8.1 RadioMedix Details
2.8.2 RadioMedix Major Business
2.8.3 RadioMedix Oncology Radiopharmaceutical Product and Services
2.8.4 RadioMedix Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 RadioMedix Recent Developments/Updates
2.9 RayzeBio
2.9.1 RayzeBio Details
2.9.2 RayzeBio Major Business
2.9.3 RayzeBio Oncology Radiopharmaceutical Product and Services
2.9.4 RayzeBio Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 RayzeBio Recent Developments/Updates
2.10 Telix Pharmaceuticals Limited
2.10.1 Telix Pharmaceuticals Limited Details
2.10.2 Telix Pharmaceuticals Limited Major Business
2.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product and Services
2.10.4 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Telix Pharmaceuticals Limited Recent Developments/Updates
2.11 Theragnostics Ltd
2.11.1 Theragnostics Ltd Details
2.11.2 Theragnostics Ltd Major Business
2.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Product and Services
2.11.4 Theragnostics Ltd Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Theragnostics Ltd Recent Developments/Updates
2.12 Vect-Horus
2.12.1 Vect-Horus Details
2.12.2 Vect-Horus Major Business
2.12.3 Vect-Horus Oncology Radiopharmaceutical Product and Services
2.12.4 Vect-Horus Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Vect-Horus Recent Developments/Updates
3 Competitive Environment: Oncology Radiopharmaceutical by Manufacturer
3.1 Global Oncology Radiopharmaceutical Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oncology Radiopharmaceutical Revenue by Manufacturer (2018-2023)
3.3 Global Oncology Radiopharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oncology Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oncology Radiopharmaceutical Manufacturer Market Share in 2022
3.4.2 Top 6 Oncology Radiopharmaceutical Manufacturer Market Share in 2022
3.5 Oncology Radiopharmaceutical Market: Overall Company Footprint Analysis
3.5.1 Oncology Radiopharmaceutical Market: Region Footprint
3.5.2 Oncology Radiopharmaceutical Market: Company Product Type Footprint
3.5.3 Oncology Radiopharmaceutical Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oncology Radiopharmaceutical Market Size by Region
4.1.1 Global Oncology Radiopharmaceutical Sales Quantity by Region (2018-2029)
4.1.2 Global Oncology Radiopharmaceutical Consumption Value by Region (2018-2029)
4.1.3 Global Oncology Radiopharmaceutical Average Price by Region (2018-2029)
4.2 North America Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.3 Europe Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.4 Asia-Pacific Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.5 South America Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.6 Middle East and Africa Oncology Radiopharmaceutical Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
5.2 Global Oncology Radiopharmaceutical Consumption Value by Type (2018-2029)
5.3 Global Oncology Radiopharmaceutical Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
6.2 Global Oncology Radiopharmaceutical Consumption Value by Application (2018-2029)
6.3 Global Oncology Radiopharmaceutical Average Price by Application (2018-2029)
7 North America
7.1 North America Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
7.2 North America Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
7.3 North America Oncology Radiopharmaceutical Market Size by Country
7.3.1 North America Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
7.3.2 North America Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
8.2 Europe Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
8.3 Europe Oncology Radiopharmaceutical Market Size by Country
8.3.1 Europe Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
8.3.2 Europe Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oncology Radiopharmaceutical Market Size by Region
9.3.1 Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oncology Radiopharmaceutical Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
10.2 South America Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
10.3 South America Oncology Radiopharmaceutical Market Size by Country
10.3.1 South America Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
10.3.2 South America Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oncology Radiopharmaceutical Market Size by Country
11.3.1 Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oncology Radiopharmaceutical Market Drivers
12.2 Oncology Radiopharmaceutical Market Restraints
12.3 Oncology Radiopharmaceutical Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oncology Radiopharmaceutical and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncology Radiopharmaceutical
13.3 Oncology Radiopharmaceutical Production Process
13.4 Oncology Radiopharmaceutical Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncology Radiopharmaceutical Typical Distributors
14.3 Oncology Radiopharmaceutical Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Oncology Radiopharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncology Radiopharmaceutical Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Oncology Radiopharmaceutical Product and Services
Table 6. Novartis Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Chimeric Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 9. Chimeric Therapeutics Limited Major Business
Table 10. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product and Services
Table 11. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Chimeric Therapeutics Limited Recent Developments/Updates
Table 13. Fusion Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Fusion Pharma Major Business
Table 15. Fusion Pharma Oncology Radiopharmaceutical Product and Services
Table 16. Fusion Pharma Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Fusion Pharma Recent Developments/Updates
Table 18. Lantheus Medical lmaging, Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Lantheus Medical lmaging, Inc. Major Business
Table 20. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product and Services
Table 21. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lantheus Medical lmaging, Inc. Recent Developments/Updates
Table 23. NanoMab Basic Information, Manufacturing Base and Competitors
Table 24. NanoMab Major Business
Table 25. NanoMab Oncology Radiopharmaceutical Product and Services
Table 26. NanoMab Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. NanoMab Recent Developments/Updates
Table 28. NuView Life Sciences. Basic Information, Manufacturing Base and Competitors
Table 29. NuView Life Sciences. Major Business
Table 30. NuView Life Sciences. Oncology Radiopharmaceutical Product and Services
Table 31. NuView Life Sciences. Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. NuView Life Sciences. Recent Developments/Updates
Table 33. PentixaPharm GmbHPrecirix Basic Information, Manufacturing Base and Competitors
Table 34. PentixaPharm GmbHPrecirix Major Business
Table 35. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product and Services
Table 36. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. PentixaPharm GmbHPrecirix Recent Developments/Updates
Table 38. RadioMedix Basic Information, Manufacturing Base and Competitors
Table 39. RadioMedix Major Business
Table 40. RadioMedix Oncology Radiopharmaceutical Product and Services
Table 41. RadioMedix Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. RadioMedix Recent Developments/Updates
Table 43. RayzeBio Basic Information, Manufacturing Base and Competitors
Table 44. RayzeBio Major Business
Table 45. RayzeBio Oncology Radiopharmaceutical Product and Services
Table 46. RayzeBio Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. RayzeBio Recent Developments/Updates
Table 48. Telix Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 49. Telix Pharmaceuticals Limited Major Business
Table 50. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product and Services
Table 51. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Telix Pharmaceuticals Limited Recent Developments/Updates
Table 53. Theragnostics Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Theragnostics Ltd Major Business
Table 55. Theragnostics Ltd Oncology Radiopharmaceutical Product and Services
Table 56. Theragnostics Ltd Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Theragnostics Ltd Recent Developments/Updates
Table 58. Vect-Horus Basic Information, Manufacturing Base and Competitors
Table 59. Vect-Horus Major Business
Table 60. Vect-Horus Oncology Radiopharmaceutical Product and Services
Table 61. Vect-Horus Oncology Radiopharmaceutical Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Vect-Horus Recent Developments/Updates
Table 63. Global Oncology Radiopharmaceutical Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Oncology Radiopharmaceutical Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Oncology Radiopharmaceutical Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Oncology Radiopharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Oncology Radiopharmaceutical Production Site of Key Manufacturer
Table 68. Oncology Radiopharmaceutical Market: Company Product Type Footprint
Table 69. Oncology Radiopharmaceutical Market: Company Product Application Footprint
Table 70. Oncology Radiopharmaceutical New Market Entrants and Barriers to Market Entry
Table 71. Oncology Radiopharmaceutical Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Oncology Radiopharmaceutical Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Oncology Radiopharmaceutical Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Oncology Radiopharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Oncology Radiopharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Oncology Radiopharmaceutical Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Oncology Radiopharmaceutical Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Oncology Radiopharmaceutical Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Oncology Radiopharmaceutical Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Oncology Radiopharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Oncology Radiopharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Oncology Radiopharmaceutical Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Oncology Radiopharmaceutical Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Oncology Radiopharmaceutical Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Oncology Radiopharmaceutical Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Oncology Radiopharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Oncology Radiopharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Oncology Radiopharmaceutical Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Oncology Radiopharmaceutical Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Oncology Radiopharmaceutical Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Oncology Radiopharmaceutical Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Oncology Radiopharmaceutical Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Oncology Radiopharmaceutical Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Oncology Radiopharmaceutical Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Oncology Radiopharmaceutical Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Oncology Radiopharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Oncology Radiopharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Oncology Radiopharmaceutical Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Oncology Radiopharmaceutical Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Oncology Radiopharmaceutical Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Oncology Radiopharmaceutical Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Oncology Radiopharmaceutical Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Oncology Radiopharmaceutical Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Oncology Radiopharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Oncology Radiopharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Oncology Radiopharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Oncology Radiopharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Oncology Radiopharmaceutical Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Oncology Radiopharmaceutical Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Oncology Radiopharmaceutical Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Oncology Radiopharmaceutical Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Oncology Radiopharmaceutical Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Oncology Radiopharmaceutical Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Oncology Radiopharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Oncology Radiopharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Oncology Radiopharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Oncology Radiopharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Oncology Radiopharmaceutical Raw Material
Table 131. Key Manufacturers of Oncology Radiopharmaceutical Raw Materials
Table 132. Oncology Radiopharmaceutical Typical Distributors
Table 133. Oncology Radiopharmaceutical Typical Customers
List of Figures
Figure 1. Oncology Radiopharmaceutical Picture
Figure 2. Global Oncology Radiopharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncology Radiopharmaceutical Consumption Value Market Share by Type in 2022
Figure 4. Oral Drugs Examples
Figure 5. Intravenous Drugs Examples
Figure 6. Other Examples
Figure 7. Global Oncology Radiopharmaceutical Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Oncology Radiopharmaceutical Consumption Value Market Share by Application in 2022
Figure 9. Hospitals and Clinics Examples
Figure 10. Pharmaceutical Company Examples
Figure 11. Research Center Examples
Figure 12. Other Examples
Figure 13. Global Oncology Radiopharmaceutical Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Oncology Radiopharmaceutical Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Oncology Radiopharmaceutical Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Oncology Radiopharmaceutical Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Oncology Radiopharmaceutical Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Oncology Radiopharmaceutical Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Oncology Radiopharmaceutical by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Oncology Radiopharmaceutical Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Oncology Radiopharmaceutical Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Oncology Radiopharmaceutical Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Oncology Radiopharmaceutical Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Oncology Radiopharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Oncology Radiopharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Oncology Radiopharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Oncology Radiopharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Oncology Radiopharmaceutical Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Oncology Radiopharmaceutical Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Oncology Radiopharmaceutical Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Oncology Radiopharmaceutical Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Oncology Radiopharmaceutical Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Oncology Radiopharmaceutical Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Oncology Radiopharmaceutical Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Oncology Radiopharmaceutical Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Oncology Radiopharmaceutical Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Oncology Radiopharmaceutical Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Oncology Radiopharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Oncology Radiopharmaceutical Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Oncology Radiopharmaceutical Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Oncology Radiopharmaceutical Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Oncology Radiopharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Oncology Radiopharmaceutical Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Oncology Radiopharmaceutical Consumption Value Market Share by Region (2018-2029)
Figure 55. China Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Oncology Radiopharmaceutical Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Oncology Radiopharmaceutical Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Oncology Radiopharmaceutical Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Oncology Radiopharmaceutical Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Oncology Radiopharmaceutical Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Oncology Radiopharmaceutical Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Oncology Radiopharmaceutical Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Oncology Radiopharmaceutical Market Drivers
Figure 76. Oncology Radiopharmaceutical Market Restraints
Figure 77. Oncology Radiopharmaceutical Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Oncology Radiopharmaceutical in 2022
Figure 80. Manufacturing Process Analysis of Oncology Radiopharmaceutical
Figure 81. Oncology Radiopharmaceutical Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
| ※参考情報 腫瘍学放射性医薬品は、がん治療および診断において重要な役割を果たす医薬品で、放射性同位元素を含む薬剤です。これらの医薬品は、特定の細胞や組織に集積し、放射線を放出して、がん細胞を破壊するか、がんの有無を検出するために使用されます。本稿では、腫瘍学放射性医薬品の概念を、定義、特徴、種類、用途、関連技術などを中心に解説します。 腫瘍学放射性医薬品の定義としては、放射性同位元素を利用した医薬品であり、主に腫瘍の診断及び治療に用いられることを指します。これらの医薬品は、放射線を発生させる性質を持ち、がん細胞やその周辺組織に特異的に集積することが期待されています。放射性医薬品は、主に一時的に放射能を持つ放射性同位元素を用いていますが、薬剤の安全性と効果を高めるために、従来の化学療法剤や抗がん剤と組み合わせて利用されることもあります。 腫瘍学放射性医薬品には、いくつかの特徴があります。まず一つ目は、ターゲット治療に特化している点です。放射性医薬品はがん細胞に選択的に結合し、局所的に放射線を放出することで、周囲の正常組織への影響を最小限に抑えることができます。二つ目の特徴として、非侵襲的な診断方法であることが挙げられます。PETスキャンやSPECTスキャンなど、放射性医薬品を用いたイメージング技術は、体内のがんの状態を把握する上で非常に有用です。三つ目は、治療効果の可視化です。放射性同位元素の放射線は、がん細胞に対して直接的に作用するだけでなく、放射性医薬品の分布状況を追跡することで、治療の効果をモニタリングすることができます。 腫瘍学放射性医薬品の種類としては、主に3つのカテゴリーに分けることができます。第一に、診断用放射性医薬品です。これらは、PETやSPECTなどの画像診断に用いられ、がんの早期発見や病状評価に役立ちます。代表的な例には、フルオロデオキシグルコース（FDG）やガリウム68、テクネチウムなどがあります。第二に、治療用放射性医薬品です。これらは、がん細胞を直接攻撃し、治療を目的としています。例としては、ヨウ素131やラジウム223などがあります。これらは特定のがんタイプに対する選択的な作用を持っており、局所的に高い放射線量を提供することができます。第三に、放射免疫療法に用いられる放射性医薬品もあります。これらは、抗体に放射性同位元素を結合させ、がん細胞に導入する方法です。例えば、アステテクニウム-99mなどの放射性同位元素を利用した薬剤が開発されています。 腫瘍学放射性医薬品の用途は多岐にわたります。まず、早期診断のために使用されることが一般的です。特に、FDG-PET検査は、さまざまながんの早期発見において非常に有効とされています。また、腫瘍の再発の有無や広がりの評価にも利用されます。さらに、放射性治療は特定のがんの治療において急速に進歩しており、特に甲状腺がんや前立腺がん、骨転移に対する治療効果が期待されています。 関連技術としては、画像診断技術が挙げられます。PET（陽電子放出断層撮影）やSPECT（単一光子放射断層撮影）は、腫瘍学放射性医薬品の効果的な診断手法として広く利用されています。これらの技術は、体内の生理的現象をリアルタイムで可視化し、腫瘍の特性や機能に関する情報を提供します。さらに、放射性医薬品の製造には先進的な技術が要求されます。放射性同位元素は、多くの場合、加速器や原子炉で生成され、それらを化学的に処理することで医薬品としての形にされます。この過程には、高度な技術が必要であり、製造過程の安全性や品質管理も重要な要素となります。 腫瘍学放射性医薬品の未来については、さらなる研究と開発が進められることが期待されています。現在でも新しい放射性同位元素や、その結合体としての医薬品が開発されており、今後の治療法や診断法の革新に寄与する可能性があります。特に、個別化医療の進展に伴い、患者一人一人のがんの特性に応じた放射性医薬品への需要が高まることが予想されます。 最後に、腫瘍学放射性医薬品の利用に際しては、安全性や副作用に対する注意が必要です。放射線による被曝リスクは常に存在するため、医療従事者は患者の状態やリスクを総合的に判断し、適切な使用法を選択しなければなりません。また、患者自身も、がん治療における放射性医薬品の利用に関して十分な説明を受け、自らの選択に基づいて治療を受けることが重要です。 腫瘍学放射性医薬品は、がん治療と診断の未来において重要な位置を占めるものであり、今後ますますその可能性が広がっていくことでしょう。医療分野における技術革新とともに、腫瘍学放射性医薬品の発展が、がんとの戦いにおいて新たな武器となることを期待しています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
